Independent voices from the TWT Communities
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages _ at least for the time being _ that have left patients and parents frightened about missing life-saving treatments.
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages _ at least for the time being _ that have left patients and parents frightened about missing life-saving treatments.
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have left patients and parents frightened about missing life-saving treatments.
Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments.
